GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FHTX · Jun 30, 2026

Foghorn Therapeutics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001628280-26-053819General Corporate

Capex intensity45thOwn-history percentile · N=11

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.31% · OPTIONAL · VALID

Operating cash generation100thOwn-history percentile · N=11

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-111.03% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

112.68% · CORE · NOT_ENOUGH_HISTORY

Operating margin100thOwn-history percentile · N=11

Evidence method

Level · gp.fundamentals.operating_margin

-54.78% · CORE · VALID

R&D intensity0thOwn-history percentile · N=11

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

115.25% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=11

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

15.87% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History8 statesHistory building

Sep 30, 20240/6 normalizedLevel 3 Dec 31, 20240/6 normalizedLevel 3 Mar 31, 20250/6 normalizedLevel 3 Jun 30, 20250/6 normalizedLevel 3 Sep 30, 20255/6 normalizedLevel 3 Dec 31, 20255/6 normalizedLevel 3 Mar 31, 20265/6 normalizedLevel 3 Jun 30, 20265/6 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: 0.00%
Current: 0.31%
Delta: 0.31%

Cash Generation Increased

Previous: -773.37%
Current: -111.03%
Delta: 662.34%

Growth Increased

Previous: -45.11%
Current: 112.68%
Delta: 157.79%

Profitability Increased

Previous: -660.33%
Current: -54.78%
Delta: 605.55%

R And D Intensity Decreased

Previous: 558.89%
Current: 115.25%
Delta: -443.64%

Sbc Intensity Decreased

Previous: 72.94%
Current: 15.87%
Delta: -57.08%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Compared To · Pharmaceutical Preparations peers →Transitioned To · FHTX Fundamental State →Transitioned To · FHTX CAPEX_INTENSITY_INCREASED →Transitioned To · FHTX CASH_GENERATION_INCREASED →Transitioned To · FHTX GROWTH_INCREASED →Transitioned To · FHTX PROFITABILITY_INCREASED →Transitioned To · FHTX R_AND_D_INTENSITY_DECREASED →Transitioned To · FHTX SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.